Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 24.10
+0.20 (0.84%)
Apr 29, 2026, 12:47 PM CET
Ryvu Therapeutics Revenue
In the year 2025, Ryvu Therapeutics had annual revenue of 87.70M PLN, down -13.98%. Ryvu Therapeutics had revenue of 25.78M in the quarter ending December 31, 2025, a decrease of -9.50%.
Revenue
87.70M
Revenue Growth
-13.98%
P/S Ratio
6.30
Revenue / Employee
384.66K
Employees
228
Market Cap
552.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 87.70M | -14.26M | -13.98% |
| Dec 31, 2024 | 101.96M | 34.67M | 51.51% |
| Dec 31, 2023 | 67.30M | -1.14M | -1.67% |
| Dec 31, 2022 | 68.44M | 33.02M | 93.25% |
| Dec 31, 2021 | 35.41M | -1.54M | -4.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| BIOTON | 282.52M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Molecure | 6.52M |
| NanoGroup | -6.90K |
| Poltreg | 250.00K |
| Urteste | 1.80M |
Ryvu Therapeutics News
- 1 year ago - Ryvu Therapeutics Transcript: Study Update - Transcripts